Clinical Follow Up Study of 87 Patients with Sicca Symptoms (dryness of Eyes or Mouth, or Both)

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1999 Jun 25

PMID 10381486

Citations 18

Authors

M Pertovaara

M Korpela

H Uusitalo

J Pukander

A Miettinen

H Helin

A Pasternack

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the prognosis of patients with sicca symptoms and to identify the clinical and immunological factors that most sensitively predict the later development of primary Sjögren's syndrome (SS) or other connective tissue diseases.

Methods: Eighty seven patients (72 female, 15 male) with sicca symptoms were re-evaluated after a median follow up time of 11 years (range 8-17). The clinical examination included ophthalmological examination (Schirmer's test, break up time and Rose-Bengal staining). Labial salivary gland biopsy was performed and histological findings graded according to the Chisholm-Mason scale. The immunoserological tests included determination of rheumatoid factor (RF), antinuclear antibodies (ANA), anti-extractable nuclear antigen-antibodies (ENA), serum immunoglobulins IgA, IgG, and IgM, and serum beta2-microglobulin (beta2m).

Results: At follow up 31 patients (36%) fulfilled modified Californian criteria (salivary flow measurements were not performed and Chisholm-Mason grades 3-4 were regarded as diagnostic histological findings) for possible or definite SS. Likewise, a significant progression of the histological findings was observed. Labial salivary gland re-biopsy was performed in 42 patients with grade 0-2 findings at baseline, progression to grades 3-4 being observed in 21 (50%) at follow up. The patients who later developed SS were at baseline significantly older (mean (SD) 52 (9) v 44 (14) years, p</=0.005) compared with those not fulfilling the SS criteria at follow up; they also had significantly higher serum beta2m (p</=0.0005) and IgG concentrations (p</=0.005), and they had positive ANA more frequently (p</=0.01).

Conclusion: These results suggest that high age, increased values of serum beta2m, ANA positivity and increased concentrations of serum IgG, might be useful indicators for the subsequent development of SS in patients with sicca symptoms. The prognosis of patients with these symptoms was favourable, and the clinical course was benign even in the 36% of patients who developed SS. No cases of lymphoma were observed.

Citing Articles

Salivary Flow Rate in Patients with Sjögren's Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity.

Caraba A, Roman D, Crisan V, Iurciuc S, Iurciuc M Int J Mol Sci. 2025; 26(1.

PMID: 39795957 PMC: 11720050. DOI: 10.3390/ijms26010101.

Emerging biologic frontiers for Sjogren's syndrome: Unveiling novel approaches with emphasis on extra glandular pathology.

Li X, Maitiyaer M, Tan Q, Huang W, Liu Y, Liu Z Front Pharmacol. 2024; 15:1377055.

PMID: 38828450 PMC: 11140030. DOI: 10.3389/fphar.2024.1377055.

Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.

Noll B, Beckman M, Bahrani Mougeot F, Mougeot J Int J Mol Sci. 2024; 25(9).

PMID: 38732189 PMC: 11084897. DOI: 10.3390/ijms25094973.

Defining the Role of Monocytes in Sjögren's Syndrome.

Sequi-Sabater J, Beretta L Int J Mol Sci. 2022; 23(21).

PMID: 36361554 PMC: 9654893. DOI: 10.3390/ijms232112765.

Reduced tear thrombospondin-1/matrix metalloproteinase-9 ratio can aid in detecting Sjögren's syndrome etiology in patients with dry eye.

Masli S, Akpek E Clin Transl Sci. 2022; 15(8):1999-2009.

PMID: 35610740 PMC: 9372415. DOI: 10.1111/cts.13316.

References

Chisholm D, Mason D . Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol. 1968; 21(5):656-60. PMC: 473887. DOI: 10.1136/jcp.21.5.656. View

Talal N, Bunim J . THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med. 1964; 36:529-40. DOI: 10.1016/0002-9343(64)90101-9. View

Kassan S, Thomas T, Moutsopoulos H, Hoover R, Kimberly R, Budman D . Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978; 89(6):888-92. DOI: 10.7326/0003-4819-89-6-888. View

Martinez-Lavin M, Vaughan J, Tan E . Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med. 1979; 91(2):185-90. DOI: 10.7326/0003-4819-91-2-185. View

Forstot J, Forstot S, Greer R, Tan E . The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum. 1982; 25(2):156-60. DOI: 10.1002/art.1780250207. View

Pavlidis N, Karsh J, Moutsopoulos H . The clinical picture of primary Sjögren's syndrome: a retrospective study. J Rheumatol. 1982; 9(5):685-90. View

Fox R, Robinson C, Curd J, Kozin F, Howell F . Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986; 29(5):577-85. DOI: 10.1002/art.1780290501. View

Kriegbaum N, von Linstow M, Oxholm P, Prause J . Keratoconjunctivitis sicca in patients with primary Sjögren's syndrome. A longitudinal study of ocular parameters. Acta Ophthalmol (Copenh). 1988; 66(5):481-4. DOI: 10.1111/j.1755-3768.1988.tb04367.x. View

Ichikawa Y, Takaya M, Uchiyama M, Shimizu H, Tokunaga M, Saitoh H . Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome. Tokai J Exp Clin Med. 1988; 13(2):85-90. View

10.

Kelly C, Foster H, Pal B, Gardiner P, Malcolm A, Charles P . Primary Sjögren's syndrome in north east England--a longitudinal study. Br J Rheumatol. 1991; 30(6):437-42. DOI: 10.1093/rheumatology/30.6.437. View

11.

Markusse H, Oudkerk M, Vroom T, Breedveld F . Primary Sjögren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med. 1992; 40(3-4):125-34. View

12.

Leroy J, Pennec Y, Soulier C, Berthelot J, Letoux G, Youinou P . Follow up study of labial salivary gland lesions in primary Sjögren's syndrome. Ann Rheum Dis. 1992; 51(6):777-80. PMC: 1004745. DOI: 10.1136/ard.51.6.777. View

13.

Vitali C, Bombardieri S, Moutsopoulos H, BALESTRIERI G, Bencivelli W, Bernstein R . Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993; 36(3):340-7. DOI: 10.1002/art.1780360309. View

14.

Jonsson R, Kroneld U, Backman K, Magnusson B, Tarkowski A . Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol. 1993; 32(7):578-81. DOI: 10.1093/rheumatology/32.7.578. View

15.

Simmons-OBrien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M . One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore). 1995; 74(3):109-30. DOI: 10.1097/00005792-199505000-00001. View

16.

Zufferey P, Meyer O, Grossin M, Kahn M . Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol. 1995; 24(6):342-5. DOI: 10.3109/03009749509095178. View

17.

Kruize A, Hene R, van der Heide A, Bodeutsch C, de Wilde P, van Bijsterveld O . Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum. 1996; 39(2):297-303. DOI: 10.1002/art.1780390219. View

18.

Michalski J, Daniels T, Talal N, Grey H . Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med. 1975; 293(24):1228-31. DOI: 10.1056/NEJM197512112932404. View